Skip to main content

Table 1 Demographic and clinical characteristics of the patients included in the study

From: miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod

 

Discovery set

All sample

NEDA 3

EDA-3

No. of participants

31

19

12

Mean age (SD)

40.71 (9.81)

41.79 (10.17)

39 (9.38)

Females %

71

73.7

66.7

Mean EDSS score (SD)

1.52 (1.17)

1.5 (1.07)

1.54 (1.36)

Mean relapses in the previous 2 years

0.65 (1.54)

0.74 (1.85)

0.5 (0.9)

 

Validation set

All sample

NEDA 3

EDA-3

No. of participants

22

17

5

Mean age (SD)

44.36 (11.09)

42.65 (10.89)

50.18 (10.79)

Females %

81.8

82.4

80

Mean EDSS score (SD)

1.82 (1.28)

1.38 (1.11)

3.3 (0.27)

Mean relapses in the previous 2 years

0.45 (0.67)

0.53 (0.72)

0.2 (0.45)